Stocks

What's Going On With Helios Fairfax Partners Corporation Stock Wednesday?

By Wealth Awesome Newsroom -
Stocks & ETFs:HFPC-U.TO
Photos provided by Pexels

Helios Fairfax Partners Corporation's stock has experienced a notable decline this week, reflecting broader market sentiments.

This week, Helios Fairfax Partners Corporation (HFPC-U.TO) saw its stock price decrease by 5%, closing at US$1.71. The company hasn’t released any major news recently, but its ongoing efforts in the financial sector, particularly its offer for CAB Payments Holdings plc, are worth noting.

Advertisement

Qtrade Direct Investing

Get up to $2,000 cash back

Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.

Helios Fairfax Partners Corporation

HFPC-U.TO

Full stock page →

HFPC-U.TO

Helios Fairfax Partners Corporation

Source:WealthAwesomeWealthAwesome
$0.09 (-5.00%)
120 day period
$1.50$1.98$2.45Jan 15Apr 16Jul 14

Market cap

$185.45M

P/E

4.1x

52W high

$2.45

52W low

$1.45

1W change

-5.00%

Beta

0.20

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HFPC-U's historical volatility

HistoricalForecast68%95%
US$0.88US$1.21US$1.54US$1.87US$2.20US$2.52TodayFeb 27May 8Jul 14Aug 26Oct 9Nov 21

30-Day Vol

40.8%

Annualized

90-Day Vol

74.6%

Annualized

Trend (90d)

-39.8%

Annualized drift

90d Mean

US$1.48

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$1.63US$1.42US$1.88
60 trading daysUS$1.56US$1.27US$1.90
90 trading daysUS$1.48US$1.16US$1.89

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Investor takeaway: Keep an eye on Helios Fairfax's strategic moves, especially its acquisition efforts, as these could impact future performance despite the current price drop.

Helios Fairfax Partners Corporation's stock down 5% this week, closing at US$1.71.

The stock has a market cap of approximately US$185 million and a P/E ratio of just over 4, suggesting it may be undervalued relative to its earnings.

Bull case

Helios Fairfax has strong profit margins and consistent book value growth, which could position it well for future gains, especially if its acquisition strategies succeed.

Bear case

The recent price drop and low trading volume may signal investor hesitance, which could continue to put pressure on the stock in the near term.

Weekly Performance Overview

This week, Helios Fairfax Partners Corporation's stock price decreased by 5%, closing at US$1.71. Over the past month, the stock has seen a slight decline of 1.72%, although it remains up 16.33% year-to-date.

Company News and Catalysts

There are no major company news releases this week. However, Helios Fairfax continues to update its stakeholders on its offer for CAB Payments Holdings plc, which may influence investor sentiment in the future. Previous announcements highlighted financial results and strategic moves, including a significant increase in its credit facility.

Technical Picture

From a technical perspective, Helios Fairfax's stock is currently trading below its 50-day moving average of US$1.73 and its 200-day moving average of US$1.86. The stock's 52-week range is between US$1.45 and US$2.45, indicating it is currently at about 26% of its range. The stock's beta is low at 0.20, suggesting lower volatility compared to the overall market. Notably, trading volume has dropped significantly, with just 1 share traded against a 20-day average volume of 10,534 shares.

Insider Activity

There is no recent insider activity to report for Helios Fairfax Partners Corporation.

Conclusion

As of the latest close, Helios Fairfax Partners Corporation's stock stands at US$1.71, reflecting a neutral stance in the market. Investors may want to monitor future developments closely, especially regarding the company's acquisition strategy and financial health.


Advertisement

Sponsored links

Advertisement